Repository

Publications

Understanding Cholangiocarcinoma—perspectives from three European advocacy groups

Baucells E, Morement H, Leonardi P
Lancet Regional Health Europe. 2025 Feb 19. DOI: 10.1016/j.lanepe.2025.101239
2025 

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe

Rimassa L, Lamarca A, O'Kane G, Edeline J, McNamara M, Vogel A, Fassan M, Forner A, Kendall T, Adevar J, Casadei-Gardini A, Fornaro L, Hollebecque A, Lowery M, Macarulla T, Malka D, Mariamidze E, Niger M, Ustava A, Bridgewater J, Macias RIR, Braconi C
Lancet Regional Health Europe. 2025 Feb 19. DOI: 10.1016/j.lanepe.2024.101170
2025 

Mapping the landscape of biliary tract cancer in Europe: challenges and controversies

Rimassa L, Khan S, Groot Koerkamp B, Roessler S, Andersen J, Raggi C, Lleo A, Nault J, Calderaro J, Gabbi C, Kather J, Banales JM, Bargellini I, Morement H, Krawczyk M, Farazi P, Carpino G, Avila M, Saborowski A, Cardinale V, Braconi C, Macias RIR
Lancet Regional Health Europe. 2025 Feb 19. DOI: 10.1016/j.lanepe.2024.101171
2025 

Targeting protein hyperSUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma crosstalk

Olaizola P, Olaizola I, Fernandez de Ara M, Lapitz A, Val B, Izquierdo-Sanchez L, Fernandez-Barrena MG, Alvarez L, O'Rourke CJ, Lee-Law PY, Davies K, Gradinaru A, Jimenez-Agüero R, La Casta A, Riaño I, Macias RIR, Marin JJG, Martinez-Chantar ML, Avila MA, Aspichueta P, Andersen JB, Boulter L, Bujanda L, Rodrigues PM, Perugorria MJ, Banales JM
Hepatology. 2025 Feb 11. doi: 10.1097/HEP.0000000000001259
2025 
Funded by

Gallstones in the 21st Century

Krupa Ł, Portincasa P, Lammert F, Krawczyk M
Pol Arch Intern Med . 2025 Jan 30;135(1):16937. doi: 10.20452/pamw.16937
2025 
Join the Action
JOIN